Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model

Journal of Neurotrauma

Volumn 29, Issue 2, 2012, Pages 246-260

  Crawford, Fiona ^a,b   Crynen, Gogce ^a   Reed, Jon ^a,b   Mouzon, Benoit ^a,b   Bishop, Alex ^a   Katz, Benjamin ^a   Ferguson, Scott ^a,b   Phillips, John ^a   Ganapathi, Vani ^a   Mathura, Venkatarajan ^a,b   Roses, Allen ^c   Mullan, Michael ^a,b  

^a ROSKAMP INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

APOE; biomarkers; proteomics; TBI

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; CEREBELLIN 1; CLUSTERIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C8; EALC PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 13; GLUTATHIONE PEROXIDASE 3; HEMOGLOBIN BETA CHAIN; HEMOPEXIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MURINOGLOBULIN 1; PROTHROMBIN; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR A3K; SEROTRANSFERRIN; SYNAPTIC NUCLEAR ENVELOPE 1 ISOFORM 3; UNCLASSIFIED DRUG; VENOMBIN A;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FUNCTIONAL PROTEOMICS; INJURY SEVERITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SHAM PROCEDURE; TRAUMATIC BRAIN INJURY;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; PROGNOSIS; PROTEOMICS; RECOVERY OF FUNCTION;

EID: 84856507598     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1789     Document Type: Article

References (54)

1. Abildayeva, K., Berbée, J.F.P., Blokland, A., Jansen, P.J., Hoek, F.J., Meijer, O., Lütjohann, D., Gautier, T., Pillot, T., De Vente, J., Havekes, L.M., Ramaekers, F.C.S., Kuipers, F., Rensen, P.C.N., and Mulder, M. (2008). Human apolipoprotein C-I expression in mice impairs learning and memory functions. J. Lipid. Res. 49, 856-869.
2. Abraham, C.R., Kanemaru, K., and Mucke, L. (1993). Expression of cathepsin G-like and alpha 1-antichymotrypsin-like pro-teins in reactive astrocytes. Brain Res. 621, 222-232. (Pubitemid 23248081)
3. Ansari, M.A., Roberts, K.N., and Scheff, S.W. (2008). Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic. Biol. Med. 45, 443-452.
4. Bantscheff, M., Boesche, M., Eberhard, D., Matthieson, T., Sweetman, G., and Kuster, B. (2008). Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer. Mol. Cell Proteomics 7, 1702-1713.
5. Bellander, B.-M., Bendel, O., Von Euler, G., Ohlsson, M., and Svensson, M. (2004). Activation of microglial cells and com-plement following traumatic injury in rat entorhinal-hippo-campal slice cultures. J. Neurotrauma 21, 605-615. (Pubitemid 38656757)
6. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R Stat. Soc. Series B Stat. Methodol. 57, 289-300.
7. Bermpohl, D., You, Z., Lo, E.H., Kim, H.H., and Whalen, M.J. (2007). TNF alpha and Fas mediate tissue damage and func-tional outcome after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 27, 1806-1818. (Pubitemid 47624551)
8. Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R.E., Wyss-Coray, T., Mucke, L., and Mahley, R.W. (1999). Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867-4880. (Pubitemid 29270123)
9. Chang, E.F., Wong, R.J., Vreman, H.J., Igarashi, T., Galo, E., Sharp, F.R., Stevenson, D.K., and Noble-Haeusslein, L.J. (2003). Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after trau-matic brain injury. J. Neurosci. 23, 3689-3696. (Pubitemid 36958477)
10. Chen, Y., Lomnitski, L., Michaelson, D.M., and Shohami, E. (1997). Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80, 1255-1262. (Pubitemid 27359807)
11. Colton, C.A., Needham, L.K., Brown, C., Cook, D., Rasheed, K., Burke, J.R., Strittmatter, W.J., Schmechel, D.E., and Vitek, M.P. (2004). APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J. Neuroimmunol. 147, 62-67. (Pubitemid 38114948)
12. Conti, A., Sanchez-Ruiz, Y., Bachi, A., Beretta, L., Grandi, E., Beltramo, M., and Alessio, M. (2004). Proteome study of hu-man cerebrospinal fluid following traumatic brain injury in-dicates fibrin(ogen) degradation products as trauma-associated markers. J. Neurotrauma 21, 854-863. (Pubitemid 38998913)
13. Crawford, F., Wood, M., Ferguson, S., Mathura, V., Gupta, P., Humphrey, J., Mouzon, B., Laporte, V., Margenthaler, E., and O'Steen, B. (2009). Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury. Neuroscience 159, 1349-1362.
14. Crawford, F.C., Vanderploeg, R.D., Freeman, M.J., Singh, S., Waisman, M., Michaels, L., Abdullah, L., Warden, D., Lipsky, R., Salazar, A., and Mullan, M.J. (2002). APOE genotype in-fluences acquisition and recall following traumatic brain injury. Neurology 58, 1115-1118. (Pubitemid 34298559)
15. Dash, P.K., Zhao, J., Hergenroeder, G., and Moore, A.N. (2010). Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurother-apeutics 7, 100-114.
16. Deshpande, A.A., Millis, S.R., Zafonte, R.D., Hammond, F.M., and Wood, D.L. (1997). Risk factors for acute care transfer among traumatic brain injury patients. Arch. Phys. Med. Re-habil. 78, 350-352. (Pubitemid 27171831)
17. Dzietko, M., Boos, V., Sifringer, M., Polley, O., Gerstner, B., Genz, K., Endesfelder, S., Borner, C., Jacotot, E., Chauvier, D., Obladen, M., Buhrer, C., and Felderhoff-Mueser, U. (2008). A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann. Neurol. 64, 664-673.
18. Ferguson, S., Mouzon, B., Kayihan, G., Wood, M., Poon, F., Doore, S., Mathura, V., Humphrey, J., O'Steen, B., Hayes, R., Roses, A., Mullan, M., and Crawford, F. (2010). Apolipopro-tein E genotype and oxidative stress response to traumatic brain injury. Neuroscience 168, 811-819.
19. Fu, Q., Garnham, C.P., Elliott, S.T., Bovenkamp, D.E., and Van Eyk, J.E. (2005). A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, al-bumin and IgG depletion, and two-dimensional gel electro-phoresis. Proteomics 5, 2656-2664. (Pubitemid 40966493)
20. Gilar, M., Olivova, P., Daly, A.E., and Gebler, J.C. (2005). Or-thogonality of separation in two-dimensional liquid chroma-tography. Anal. Chem. 77, 6426-6434. (Pubitemid 41436983)
21. Gros-Louis, F., Dupré, N., Dion, P., Fox, M.A., Laurent, S., Verreault, S., Sanes, J.R., Bouchard, J.P., and Rouleau, GA. (2006). Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat. Genet. 39, 80-85. (Pubitemid 46026505)
22. Han, B.H., DeMattos, R.B., Dugan, L.L., Kim-Han, J.S., Brendza, R.P., Fryer, J.D., Kierson, M., Cirrito, J., Quick, K., Harmony, J.A., Aronow, B.J., and Holtzman, D.M. (2001). Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat. Med. 7, 338-343. (Pubitemid 32224350)
23. Hannay, H.J., Feldman, Z., Phan, P., Keyani, A., Panwar, N., Goodman, J.C., and Robertson, C.S. (1999). Validation of a controlled cortical impact model of head injury in mice. J. Neurotrauma 16, 1103-1114.
24. Hausmann, R., and Betz, P. (2001). Course of glial immunore-activity for vimentin, tenascin and alpha1-antichymotrypsin after traumatic injury to human brain. Int. J. Legal Med. 114, 338-342. (Pubitemid 32691856)
25. Hill, E.G., Schwacke, J.H., Comte-Walters, S., Slate, E.H., Oberg, A.L., Eckel-Passow, J.E., Therneau, T.M., and Schey, K.L. (2008). A statistical model for iTRAQ data analysis. J. Pro-teome Res. 7, 3091-3101.
26. Iwata, A., Browne, K.D., Chen, X.-H., Yuguchi, T., and Smith, D.H. (2005). Traumatic brain injury induces biphasic upregu-lation of ApoE and ApoJ protein in rats. J. Neurosci. Res. 82, 103-114. (Pubitemid 41604802)
27. Jordan, B.D. (2007). Genetic influences on outcome following traumatic brain injury. Neurochem. Res. 32, 905-915. (Pubitemid 46481316)
28. Kato, K., Kishi, T., Kamachi, T., Akisada, M., Oka, T., Mid-orikawa, R., Takio, K., Dohmae, N., Bird, P.I., and Sun, J. (2001). Serine proteinase inhibitor 3 and murinoglobulin I are potent inhibitors of neuropsin in adult mouse brain. J. Biol. Chem. 276, 14562.
29. Kay, A., Petzold, A., Kerr, M., Keir, G., Thompson, E., and Ni-coll, J. (2003a). Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 34, e240-e243.
30. Kay, A.D., Day, S.P., Kerr, M., Nicoll, J.A.R., Packard, C.J., and Caslake, M.J. (2003b). Remodeling of cerebrospinal fluid li-poprotein particles after human traumatic brain injury. J. Neurotrauma 20, 717-723. (Pubitemid 36993447)
31. Keep, R.F., Xiang, J., Ennis, S.R., Andjelkovic, A., Hua, Y., Xi, G., and Hoff, J.T. (2008). Blood-brain barrier function in intrace-rebral hemorrhage. Acta. Neurochir. Suppl. 105, 73-77.
32. Kobeissy, F.H., Sadasivan, S., Oli, M.W., Robinson, G., Larner, S.F., Zhang, Z., Hayes, R.L., and Wang, K.K.W. (2008). Neu-roproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Prot. Clin. Appl. 2, 1467-1483.
33. Kossmann, T., Hans, V.H., Imhof, H.G., Stocker, R., Grob, P., Trentz, O., and Morganti-Kossmann, C. (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4, 311-317.
34. Kramer, A.H., Zygun, D.A., Bleck, T.P., Dumont, A.S., Kassell, N.F., and Nathan, B. (2009). Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit. Care 10, 157-165.
35. Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Ta-vernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fiévet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., Investigators, E.D.I., de Pancorbo, M.M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossù, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soini-nen, H., Ritchie, K., Blanché, H., Dartigues, J.-F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alpérovitch, A., Lathrop, M., and Amouyel, P. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzhei-mer's disease. Nat. Genet. 41, 1094-1099.
36. Lauer, S.J., Walker, D., Elshourbagy, N.A., Reardon, C.A., Levy-Wilson, B., and Taylor, J.M. (1988). Two copies of the human apolipoprotein C-I gene are linked closely to the apolipopro-tein E gene. J. Biol. Chem. 263, 7277-7286.
37. Liu, H.M., and Sturner, W.Q. (1988). Extravasation of plasma proteins in brain trauma. Forensic Sci. Int. 38, 285-295.
38. Papassotiropoulos, A., Wollmer, M.A., Tsolaki, M., Brunner, F., Molyva, D., Lutjohann, D., Nitsch, R.M., and Hock, C. (2005). A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J. Clin. Psychiatry 66, 940-947 (Pubitemid 41032839)
39. Sabo, T., Lomnitski, L., Nyska, A., Beni, S., Maronpot, R.R., Shohami, E., Roses, A.D., and Michaelson, D.M. (2000). Susceptibility of transgenic mice expressing human apoli-poprotein E to closed head injury: the allele E3 is neuro-protective whereas E4 increases fatalities. Neuroscience 101, 879-884.
40. Saggar, V., Mittal, R.S., and Vyas, M.C. (2009). Hemostatic abnormalities in patients with closed head injuries and their role in predicting early mortality. J. Neurotrauma 26, 1665-1668.
41. Serra-Grabulosa, J.M., Salgado-Pineda, P., Junque, C., Sole-Padulles, C., Moral, P., Lopez-Alomar, A., Lopez, T., Lopez-Guillen, A., Bargallo, N., Mercader, J.M., Clemente, I.C., and Bartres-Faz, D. (2003). Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics 4, 141-146. (Pubitemid 36612197)
42. Shao, J., Xi, G., Hua, Y., Schallert, T., and Felt, B.T. (2006). Al-terations in intracerebral hemorrhage-induced brain injury in the iron deficient rat. Acta Neurochir. Suppl. 96, 183-187.
43. Slemmon, J.R., Goldowitz, D., Blacher, R., and Morgan, J.I. (1988). Evidence for the transneuronal regulation of cerebellin biosynthesis in developing Purkinje cells. J. Neurosci. 8, 4603-4611. (Pubitemid 19015141)
44. Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.O., Westman, E., Kinsey, A., Güntert, A., Proitsi, P., Powell, J., Causevic, M., Killick, R., Lunnon, K., Lynham, S., Broadstock, M., Choudhry, F., Howlett, D.R., Williams, R.J., Sharp, S.I., Mitchelmore, C., Tunnard, C., Leung, R., Foy, C., O'Brien, D., Breen, G., Furney, S.J., Ward, M., Kloszewska, I., Mecocci, P., Soininen, H., Tso-laki, M., Vellas, B., Hodges, A., Murphy, D.G., Parkins, S., Richardson, J.C., Resnick, S.M., Ferrucci, L., Wong, D.F., Zhou, Y., Muehlboeck, S., Evans, A., Francis, P.T., Spenger, C., and Lovestone, S. (2010). Association of plasma clusterin concen-tration with severity, pathology, and progression in Alzhei-mer disease. Arch. Gen. Psychiatry 67, 739-748.
45. Urban, S. (2006). Rhomboid proteins: conserved membrane pro-teases with divergent biological functions. Genes Dev. 20, 3054-3068. (Pubitemid 44790621)
46. VanLandingham, J.W., Cekic, M., Cutler, S., Hoffman, S.W., and Stein, D.G. (2007). Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci. Lett. 425, 94-98. (Pubitemid 47410371)
47. Vitek, M.P., Brown, C.M., and Colton, CA. (2009). APOE ge-notype-specific differences in the innate immune response. Neurobiol. Aging 30, 1350-1360.
48. Wang, H., Durham, L., Dawson, H., Song, P., Warner, D.S., Sullivan, P.M., Vitek, M.P., and Laskowitz, D.T. (2007). An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neu-roscience 144, 1324-1333. (Pubitemid 46123809)
49. Wang, K.K.W., Ottens, A.K., Liu, M.C., Lewis, S.B., Meegan, C., Oli, M.W., Tortella, F.C., and Hayes, R.L. (2005). Proteomic identification of biomarkers of traumatic brain injury. Expert Rev. Proteomics 2, 603-614. (Pubitemid 41139842)
50. Wolach, B., Sazbon, L., Gavrieli, R., Broda, A., and Schlesinger, M. (2001). Early immunological defects in comatose patients after acute brain injury. J. Neurosurg. 94, 706-711. (Pubitemid 32799617)
51. Wong, C.G., and Ladisch, S. (1983). Retention of gangliosides in serum delipidated by diisopropyl ether-1-butanol extraction. J. Lipid Res. 24, 666-669. (Pubitemid 13059200)
52. Wu, J., Hua, Y., Keep, R.F., Nakamura, T., Hoff, J.T., and Xi, G. (2003). Iron and iron-handling proteins in the brain after in-tracerebral hemorrhage. Stroke 34, 2964-2969. (Pubitemid 37517778)
53. Xu, P.T., Schmechel, D., Rothrock-Christian, T., Burkhart, D.S., Qiu, H.L., Popko, B., Sullivan, P., Maeda, N., Saunders, A.M., Roses, A.D., and Gilbert, J.R. (1996). Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3, 229-245. (Pubitemid 26391326)
54. Yao, D.L., Masonic, K., Petullo, D., Ling Li, Y., Lincoln, C., Wibberley, L., Alderson, R.F., and Antonaccio, M. (1999). Pretreatment with intravenous FGF-13 reduces infarct volume and ameliorates neurological deficits following focal cerebral ischemia in rats. Brain Res. 818, 140-146. (Pubitemid 29227293)